These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34068133)

  • 1. Beyond Abscopal Effect: A Meta-Analysis of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer.
    Fiorica F; Tebano U; Gabbani M; Perrone M; Missiroli S; Berretta M; Giuliani J; Bonetti A; Remo A; Pigozzi E; Tontini A; Napoli G; Luca N; Grigolato D; Pinton P; Giorgi C
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis.
    Xu Z; Feng J; Weng Y; Jin Y; Peng M
    J Oncol; 2021; 2021():6631643. PubMed ID: 33488711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis.
    Sha CM; Lehrer EJ; Hwang C; Trifiletti DM; Mackley HB; Drabick JJ; Zaorsky NG
    Radiother Oncol; 2020 Oct; 151():141-148. PubMed ID: 32717359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Age on the Efficacy of Immune Checkpoint Inhibitor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Yan X; Tian X; Wu Z; Han W
    Front Oncol; 2020; 10():1671. PubMed ID: 33072551
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer.
    Sumodhee S; Guo L; Bouhlel L; Picard A; Otto J; Naghavi AO; Richier Q; Lévy A; Bondiau PY; Poudenx M; Passeron T; Lacour JP; Montaudié H; Doyen J
    Cancer Radiother; 2022 Nov; 26(8):1045-1053. PubMed ID: 35927166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
    Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis.
    Kok PS; Cho D; Yoon WH; Ritchie G; Marschner I; Lord S; Friedlander M; Simes J; Lee CK
    JAMA Netw Open; 2020 Sep; 3(9):e2011809. PubMed ID: 32897371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model.
    Song HN; Jin H; Kim JH; Ha IB; Kang KM; Choi HS; Jeong HJ; Kim MY; Kim HJ; Jeong BK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data.
    Fiorica F; Cartei F; Licata A; Enea M; Ursino S; Colosimo C; Cammà C
    Cancer Treat Rev; 2010 Nov; 36(7):539-49. PubMed ID: 20334979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability.
    Backlund E; Grozman V; Egyhazi Brage S; Lewensohn R; Lindberg K; Helgadottir H
    Acta Oncol; 2023 Dec; 62(12):1921-1930. PubMed ID: 37966921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial radiotherapy with or without immune checkpoint inhibition for brain metastases: a systematic review and meta-analysis.
    He Q; Zhang C; Tang S; Li J; Ren Q
    Transl Cancer Res; 2020 Oct; 9(10):5909-5924. PubMed ID: 35117204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis.
    Peng M; Li X; Lei G; Weng YM; Hu MX; Song QB
    Onco Targets Ther; 2018; 11():7369-7383. PubMed ID: 30425525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC.
    Schett A; Rothschild SI; Curioni-Fontecedro A; Krähenbühl S; Früh M; Schmid S; Driessen C; Joerger M
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):121-131. PubMed ID: 31745593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
    Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoradiotherapy as An Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent.
    Chicas-Sett R; Zafra-Martin J; Morales-Orue I; Castilla-Martinez J; Berenguer-Frances MA; Gonzalez-Rodriguez E; Rodriguez-Abreu D; Couñago F
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
    Trommer M; Yeo SY; Persigehl T; Bunck A; Grüll H; Schlaak M; Theurich S; von Bergwelt-Baildon M; Morgenthaler J; Herter JM; Celik E; Marnitz S; Baues C
    Front Pharmacol; 2019; 10():511. PubMed ID: 31156434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.
    Dafni U; Tsourti Z; Vervita K; Peters S
    Lung Cancer; 2019 Aug; 134():127-140. PubMed ID: 31319971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.